• The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of it’s net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
• Fund Manager will follow the AMFI sector classification for deciding the investment universe for the scheme.
• The scheme may also invest some portion of the investible funds in equity / equity related instruments of other companies.
• The Scheme may also invest some portion of the investible funds in debt and money market instruments.

The fund manager builds the portfolio around the following parameters:

• Endeavors to invest according to Growth at Reasonable Price.
• Prefers companies that have a long term potential for growth.
• The fund is generally dominated by large caps, with significant allocation to mid and small caps
• Rigorous fundamental research which includes parameters like management competitiveness, business competitiveness, corporate governance, growth prospects, past track record etc.

0.25% of NAV if redeemed/switched out before 30 days from the date of allotment.